Want to join the conversation?
$JCP 2Q15 Call: Adjusted EBITDA was positive $134MM, a $95MM or 244% improvement vs.2Q14. On YTD basis adjusted EBITDA was $216MM this year vs. a negative $45MM last year, a $261MM increase. We had $92MM benefit from the sale of assets in last year’s 3Q. We expect a total of $50MM in asset sale benefit this year of which we’ve already banked $38MM.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.